Literature DB >> 10769047

Distribution and cellular localization of prostacyclin synthase in human brain.

I Siegle1, T Klein, M H Zou, P Fritz, M Kömhoff.   

Abstract

Prostacyclin (PGI(2)) is a labile, lipid-derived metabolite of arachidonic acid synthesized through the sequential action of cyclo-oxygenase (COX) and prostacyclin synthase (PGIS). In addition to its well-characterized vasodilatory and thrombolytic effects, an increasing number of studies report an important role of PGI(2) in nociception in various animal species. In this study we investigated the regional distribution of PGIS in human brain by immunohistochemistry and in situ hybridization. PGIS-immunoreactive (ir) protein was localized to blood vessels throughout the brain. Neuronal cells and glial cells, such as microglia and oligodendrocytes, also showed intense labeling. The strongest expression of PGIS was seen in large principal neurons, such as pyramidal cells of the cortex, pyramidal cells of the hippocampus, and Purkinje cells of the cerebellum. Abundance of PGIS mRNA was observed in blood vessels and large neurons and correlated well with the immunohistochemical findings. The expression of PGIS in human brain was further demonstrated by immunoblotting and detection of 6-keto-PGF (1alpha), the stable degradation product of prostacyclin in human brain homogenate. These results demonstrate a widespread expression of PGIS in the central nervous system and suggest a potentially important role of prostacylin in modulating neuronal activity in human brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10769047     DOI: 10.1177/002215540004800507

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  9 in total

1.  Protection against cytokine toxicity through endoplasmic reticulum and mitochondrial stress prevention by prostacyclin synthase overexpression in insulin-producing cells.

Authors:  Ewa Gurgul-Convey; Sigurd Lenzen
Journal:  J Biol Chem       Date:  2010-02-16       Impact factor: 5.157

2.  Elevated prostacyclin biosynthesis in mice impacts memory and anxiety-like behavior.

Authors:  Craig Vollert; Odochi Ohia; Hironari Akasaka; Casey Berridge; Ke-He Ruan; Jason L Eriksen
Journal:  Behav Brain Res       Date:  2013-10-16       Impact factor: 3.332

Review 3.  Brain regulation of thrombosis and hemostasis: from theory to practice.

Authors:  Mark J Fisher
Journal:  Stroke       Date:  2013-10-01       Impact factor: 7.914

4.  Prostacyclin synthase: upregulation during renal development and in glomerular disease as well as its constitutive expression in cultured human mesangial cells.

Authors:  Thomas Klein; Günther Klaus; Martin Kömhoff
Journal:  Mediators Inflamm       Date:  2015-01-18       Impact factor: 4.711

5.  Prostaglandin I2 upregulates the expression of anterior pharynx-defective-1α and anterior pharynx-defective-1β in amyloid precursor protein/presenilin 1 transgenic mice.

Authors:  Pu Wang; Pei-Pei Guan; Jing-Wen Guo; Long-Long Cao; Guo-Biao Xu; Xin Yu; Yue Wang; Zhan-You Wang
Journal:  Aging Cell       Date:  2016-05-30       Impact factor: 9.304

Review 6.  The Role of Eicosanoids in Alzheimer's Disease.

Authors:  Roger G Biringer
Journal:  Int J Environ Res Public Health       Date:  2019-07-18       Impact factor: 3.390

7.  Prostacyclin Promotes Degenerative Pathology in a Model of Alzheimer's Disease.

Authors:  Tasha R Womack; Craig T Vollert; Odochi Ohia-Nwoko; Monika Schmitt; Saghi Montazari; Tina L Beckett; David Mayerich; Michael Paul Murphy; Jason L Eriksen
Journal:  Front Cell Neurosci       Date:  2022-02-07       Impact factor: 5.505

8.  Expression of Prostacyclin-Synthase in Human Breast Cancer: Negative Prognostic Factor and Protection against Cell Death In Vitro.

Authors:  Thomas Klein; Jens Benders; Friederike Roth; Monika Baudler; Isabel Siegle; Martin Kömhoff
Journal:  Mediators Inflamm       Date:  2015-07-27       Impact factor: 4.711

9.  Prostacyclin promotes oligodendrocyte precursor recruitment and remyelination after spinal cord demyelination.

Authors:  C Takahashi; R Muramatsu; H Fujimura; H Mochizuki; T Yamashita
Journal:  Cell Death Dis       Date:  2013-09-12       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.